Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Baxter International Inc (NYSE:BAX)

43.31
Delayed Data
As of May 27
 -0.12 / -0.28%
Today’s Change
32.18
Today|||52-Week Range
46.95
+13.53%
Year-to-Date
BAX Regular Dividend: BAX will begin trading ex-dividend on 06/01/16 with a $0.13 dividend payable to shareholders of record as of 06/03/16.
IDEXX Laboratories: Strong Instrument Placement Drives Q1
8:49am / Zacks.com - Paid Partner Content
CEOs Make Big Buys of Their Companies Stocks
May 25 / GuruFocus News - Paid Partner Content
Shire Expects to Wrap Up Baxalta Buy on June 3
May 27 / TheStreet.com - Paid Partner Content
ResMed: Positive CAT-HF Study Results to Drive ASV Sales
May 25 / Zacks.com - Paid Partner Content
Cepheid: GeneXpert Placements High, Currency Woes Stay
May 27 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
May 25 / Zacks.com - Paid Partner Content
Qiagen, Therawis Diagnostics to Develop Breast Cancer Test
May 27 / Zacks.com - Paid Partner Content
Baxter Unveils THERANOVA Dialyser at ERA-EDTA Congress
May 25 / Zacks.com - Paid Partner Content
ResMed Posts Mixed Q3 Results, Brightree Buyout on Track
May 26 / Zacks.com - Paid Partner Content
Baxter International Officer Invests in Stake
May 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close43.43
Today’s open43.47
Day’s range43.15 - 43.55
Volume7,582,534
Average volume (3 months)8,719,377
Market cap$23.9B
Dividend yield1.20%
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-61.40%
Earnings growth (this year)+18.89%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)-40.21%
P/E ratio6.5
Price/Sales2.10
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-0.17-0.37%
JUNOJuno Therapeutics In...+0.52+1.25%
CTLTCatalent Inc-0.15-0.51%
XONIntrexon Corp-0.22-0.73%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$10.0B
Annual profit (last year)$968.0M
Net profit margin3.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
José E. Almeida
Chief Financial Officer &
Vice President
James K. Saccaro
Corporate headquarters
Deerfield, Illinois

Forecasts

Partner Offers

Search for Jobs